within Pharmacolibrary.Drugs.ATC.R;

model R03AC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.143,
    Cl             = 0.00025833333333333334,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.118,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0030833333333333333,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03AC03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Terbutaline is a selective beta-2 adrenergic agonist used primarily as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). It is also used off-label as a tocolytic agent to delay preterm labor. Terbutaline is approved and still in clinical use as an inhaled and oral medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Dyreborg, A, et al., &amp; Hostrup, M (2016). Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men. <i>Frontiers in pharmacology</i> 7 150–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2016.00150&quot;>10.3389/fphar.2016.00150</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27375484/&quot;>https://pubmed.ncbi.nlm.nih.gov/27375484</a></p></li><li><p>Sultan, K, et al., &amp; Rasool, MF (2023). Clinical pharmacokinetics of terbutaline in humans: a systematic review. <i>Naunyn-Schmiedeberg&#x27;s archives of pharmacology</i> 396(2) 213–227. DOI:<a href=&quot;https://doi.org/10.1007/s00210-022-02304-5&quot;>10.1007/s00210-022-02304-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36227333/&quot;>https://pubmed.ncbi.nlm.nih.gov/36227333</a></p></li><li><p>Lyrenäs, S, et al., &amp; Lönnerholm, G (1986). Pharmacokinetics of terbutaline during pregnancy. <i>European journal of clinical pharmacology</i> 29(5) 619–623. DOI:<a href=&quot;https://doi.org/10.1007/BF00635903&quot;>10.1007/BF00635903</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3956566/&quot;>https://pubmed.ncbi.nlm.nih.gov/3956566</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03AC03;
